title: Natriuretic response to renal interstitial hydrostatic pressure during angiotensin II blockade.
abstract: Increases in renal interstitial hydrostatic pressure (RIHP) increase urinary sodium excretion (UNaV). Experimentally increasing RIHP by direct renal interstitial volume expansion (DRIVE) has been shown to decrease proximal tubule sodium reabsorption. The purpose of the present study was to investigate whether the renin-angiotensin system modulates the natriuretic response to DRIVE. Unilateral nephrectomy and implantation of two polyethylene matrices were performed 3 wk before the acute experiment. Fractional sodium excretion (FENa), RIHP, and glomerular filtration rate (GFR) were measured before and after DRIVE in control rats (n = 9) and in rats receiving the angiotensin II (ANG II) receptor antagonist, losartan potassium (10 mg/kg i.v.; n = 10). DRIVE was achieved by infusing 100 microliters of 2.5% albumin solution directly into the renal interstitium. GFR remained unchanged by DRIVE in both groups. In control animals, DRIVE significantly increased both RIHP (delta 3.8 +/- 0.5 mmHg) and FENa (delta 0.92 +/- 0.19%). In the losartan-treated group, RIHP (delta 2.8 +/- 0.4 mmHg) and FENa (delta 1.93 +/- 0.41%) also significantly increased. The natriuretic response to DRIVE was significantly enhanced during ANG II receptor blockade compared with control animals (delta UNaV/delta RIHP = 2.01 +/- 0.67 vs. 0.44 +/- 0.17 mu eq.min-1 x mmHg-1, respectively; P < 0.05). These results suggest that the blockade of angiotensin enhances the natriuretic response to increased RIHP during DRIVE.
authors.affiliation: Department of Physiology, Mayo Clinic, Rochester, Minnesota 55905.
authors.forename: J A
authors.initials: JA
authors.lastname: Haas
authors.forename: J C
authors.initials: JC
authors.lastname: Lockhart
authors.forename: T S
authors.initials: TS
authors.lastname: Larson
authors.forename: T
authors.initials: T
authors.lastname: Henrikson
authors.forename: F G
authors.initials: FG
authors.lastname: Knox
mesh_terms: D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000818:Animals; D005110:Extracellular Space / Q000502:physiology*; D006874:Hydrostatic Pressure; D007267:Injections; D007668:Kidney / Q000502:physiology*; D008297:Male; D009318:Natriuresis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012709:Serum Albumin / Q000494:pharmacology
chemical_list: D012709:Serum Albumin; D000804:Angiotensin II